Literature DB >> 1195283

Absolute configuration of the major metabolite of 5,5-diphenylhydantoin, 5-(4'-hydroxyphenyl)-5-phenylhydantoin.

J H Poupaert, R Cavalier, M H Claesen, P A Dumont.   

Abstract

Chemical conversions, optical comparisons, and chiroptical measurements (CD) were employed to determine the absolute configuration of the enantiomers of 5-(4'-hydroxyphenyl)-5-phenylhydantoin (HPPH) (1b and 1c). Studies on a key intermediate, (-)-2-cyclohexyl-2-phenylglycine (5b), led to the reexamination of the well-known rule of Clough-Lutz-Jirgensons. Optical comparisons by means of derivatization into hydantoins and 3-phenyl-2-thiohydantoins (application of Freudenberg's rule of shift) gave conclusions which were consistent with chiroptical measurements on the above compounds. Thus, (-)-HPPH (1c), the major metabolite of 5,5-diphenylhydantoin in man, has the S configuration. This assignment was confirmed by X-ray single-crystal structure analysis of (+)-HPPH 10-(+)-camphorsulfonate (18b).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1195283     DOI: 10.1021/jm00246a024

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic-gingival hyperplasia: in vivo and in vitro study.

Authors:  I Ieiri; W Goto; K Hirata; A Toshitani; S Imayama; Y Ohyama; H Yamada; K Ohtsubo; S Higuchi
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  Percentages of the deuterium retained after para-hydroxylation of (R)(+)4-2H-phenytoin and (S)(-) 4-2H-phenytoin in rat.

Authors:  M A Moustafa; A A el-Emam; A M Abdelal; M E Metwally
Journal:  Arch Pharm Res       Date:  1991-03       Impact factor: 4.946

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.